Sectoral Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Sectoral Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,235	Closed	-$707K	–	114
2023 Q4	$707K	Sell	2,235 -23,745	-91%	-$4.62M	0.3%	65
2023 Q3	$4.39M	Buy	25,980 +248	+1%	+$46.6K	0.86%	50
2023 Q2	$5.58M	Sell	25,732 -1,148	-4%	-$246K	0.93%	47
2023 Q1	$4.88M	Buy	26,880 +5,070	+23%	+$970K	0.94%	47
2022 Q4	$4.29M	Buy	21,810 +2,500	+13%	+$536K	0.83%	52
2022 Q3	$4.34M	Sell	19,310 -4,710	-20%	-$953K	0.86%	52
2022 Q2	$3.04M	Buy	+24,020	New	+$2.76M	0.61%	66

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Sectoral Asset Management's KRTX Position: Q1 2024 in Review

Sectoral Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,235 shares — an estimated $707K sold.

Sectoral Asset Management first reported a position in KRTX in Q2 2022 and held it in 7 quarters. The position peaked at $5.58M in Q2 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Sectoral Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Sectoral Asset Management sold 2,235 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $707K.
Sectoral Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2022 and held it in 7 quarters.
Sectoral Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $5.58M in Q2 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Sectoral Asset Management's 13F filing for Q1 2024, filed 14 May 2024.